AI-driven Biomarker Model May Improve Detection of Cancer Cachexia
CHICAGO – A multimodal, artificial intelligence (AI)-driven model that analyzes routinely collected imaging and clinical information led to more...
Search/Filter
Loading...
Adjuvant PD-1 Blockade for Mismatch Repair-deficient Solid Cancers Directed by ctDNA Status Delivers Clinical Benefit
CHICAGO – Pembrolizumab (Keytruda), an anti-PD-1 antibody, cleared minimal residual disease and protected against recurrence in patients with DNA...
Neoadjuvant PD-1 Blockade in Early-stage Mismatch Repair-deficient Cancers Can Eliminate the Need for Surgery Regardless of Tumor Type
CHICAGO – PD-1 blockade with dostarlimab (Jemperli) induced complete tumor clearance and resolved the need for surgery in patients...
Oral Investigational Agent Zoldonrasib Elicits Objective Responses in Patients With KRAS G12D-mutated Lung Cancer
CHICAGO – Patients with previously treated non-small cell lung cancer (NSCLC) whose tumors harbored a KRAS G12D mutation experienced...
Adding Perioperative Pembrolizumab to Standard of Care Improves Outcomes in Patients With Newly Diagnosed Head and Neck Cancer
CHICAGO – Pembrolizumab (Keytruda) given before and after surgery to supplement adjuvant therapy improved responses and survival in patients...
AACR Launches Its Largest-ever Grant Program to Support Early-stage and Mid-career Cancer Researchers
The AACR Trailblazer Cancer Research Grant Program will award $15 million over three years CHICAGO – The American Association...
Richard Pazdur, MD, Honored With the 2025 AACR Enduring Impact Award for Transformative Service to Cancer Science and Medicine
CHICAGO – The 2025 AACR Enduring Impact Award for Transformative Service to Cancer Science and Medicine will be presented...
William Hait, MD, PhD, FAACR, Named Chief Scientific Advisor for the American Association for Cancer Research
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the appointment of William N. Hait, MD, PhD,...
AACR Announces 2025 Distinguished Public Service Award Recipients
CHICAGO – The American Association for Cancer Research (AACR) will honor leaders from government and the advocacy community with...
Some Patients May Experience Durable Disease Control Even After Discontinuing Immune Checkpoint Inhibitors for Side Effects
PHILADELPHIA – A subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy...